Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
QT

Qiuqiong Tang

AC Ascentage Pharma (Suzhou) Co.: 5 patents #4 of 26Top 20%
AL Ascentage Pharma Group Corp Limited: 3 patents #4 of 23Top 20%
Overall (2025): #20,994 of 469,880Top 5%
5
Patents 2025

Issued Patents 2025

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
12370197 Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseases Dajun Yang, Yifan Zhai, Douglas Dong FANG 2025-07-29
12268665 Combination of immunotherapies with MDM2 inhibitors Dajun Yang, Yifan Zhai, Douglas Dong FANG 2025-04-08
12233047 Pharmaceutical combination and use thereof Yifan Zhai, Dajun Yang, Douglas Dong FANG 2025-02-25
12194024 Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease Dajun Yang, Yifan Zhai, Douglas Dong FANG, Jing Deng 2025-01-14
12186304 Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint molecule Dajun Yang, Yifan Zhai, Douglas Dong FANG, Guangfeng Wang, Wentao Pan +1 more 2025-01-07